CDK1 and cancer: We hypothesize that, in addition to contributing to the unique activities of CDK1 as a cell-cycle regulator, the particular dynamic and plastic properties of CDK1 might also be exploited to successfully differentiate CDK1 from other CDKs in future cancer therapeutic design.